Answer
Nevirapine hemihydrate with zidovudine increases the risk of granulocytopenia, especially in paediatric patients, those receiving higher zidovudine doses or those with poor bone marrow reserve, particularly with advanced HIV disease; blood parameters should be carefully monitored.
Sources for this answer
- Viramune 50mg/5ml oral SuspensionBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 42Document updated
Sources checked